Measuring body weight distribution during sit-to-stand in patients with early knee osteoarthritis

2013 ◽  
Vol 38 (4) ◽  
pp. 745-750 ◽  
Author(s):  
Lynsey D. Duffell ◽  
Vivek Gulati ◽  
Dominic F.L. Southgate ◽  
Alison H. McGregor
2021 ◽  
Vol 86 ◽  
pp. 38-44
Author(s):  
Marina Petrella ◽  
Luiz Fernando A. Selistre ◽  
Paula R.M.S. Serrão ◽  
Giovanna C. Lessi ◽  
Glaucia H. Gonçalves ◽  
...  

BMJ Open ◽  
2019 ◽  
Vol 9 (5) ◽  
pp. e024065 ◽  
Author(s):  
Henrik Gudbergsen ◽  
Marius Henriksen ◽  
Eva Ejlersen Wæhrens ◽  
Anders Overgaard ◽  
Henning Bliddal ◽  
...  

IntroductionWith an increasing prevalence of citizens of older age and with overweight, the health issues related to knee osteoarthritis (OA) will intensify. Weight loss is considered a primary management strategy in patients with concomitant overweight and knee OA. However, there are no widely available and feasible methods to sustain weight loss in patients with overweight and knee OA. The present protocol describes a randomised controlled trial evaluating the efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide in a 3 mg/day dosing in patients with overweight and knee OA.Methods and analysis150 volunteer adult patients with overweight or obesity and knee OA will participate in a randomised, double-blind, placebo-controlled, parallel-group and single-centre trial. The participants will partake in a run-in diet intervention phase (week −8 to 0) including a low calorie diet and dietetic counselling. At week 0, patients will be randomised to either liraglutide 3 mg/day or liraglutide placebo 3 mg/day for 52 weeks as an add-on to dietetic guidance on re-introducing regular foods and a focus on continued motivation to engage in a healthy lifestyle. The co-primary outcomes are changes in body weight and the Knee Injury and Osteoarthritis Outcome Score pain subscale from week 0 to week 52.Ethics and disseminationThe trial has been approved by the regional ethics committee in the Capital Region of Denmark, the Danish Medicines Agency and the Danish Data Protection Agency. An external monitoring committee (The Good Clinical Practice Unit at Copenhagen University Hospitals) will oversee the trial. The results will be presented at international scientific meetings and through publications in peer-reviewed journals.Trial registration numbers2015-005163-16,NCT02905864, U1111-1171-4970Based on protocol versionV.6; 30 January 2017, 15:30 hours


2020 ◽  
Vol 39 (1) ◽  
Author(s):  
D. Ohlendorf ◽  
K. Kerth ◽  
W. Osiander ◽  
F. Holzgreve ◽  
L. Fraeulin ◽  
...  

Abstract Background The aim of this study was to collect standard reference values of the weight and the maximum pressure distribution in healthy adults aged 18–65 years and to investigate the influence of constitutional parameters on it. Methods A total of 416 healthy subjects (208 male / 208 female) aged between 18 and 65 years (Ø 38.3 ± 14.1 years) participated in this study, conducted 2015–2019 in Heidelberg. The age-specific evaluation is based on 4 age groups (G1, 18–30 years; G2, 31–40 years; G3, 41–50 years; G4, 51–65 years). A pressure measuring plate FDM-S (Zebris/Isny/Germany) was used to collect body weight distribution and maximum pressure distribution of the right and left foot and left and right forefoot/rearfoot, respectively. Results Body weight distribution of the left (50.07%) and right (50.12%) foot was balanced. There was higher load on the rearfoot (left 54.14%; right 55.09%) than on the forefoot (left 45.49%; right 44.26%). The pressure in the rearfoot was higher than in the forefoot (rearfoot left 9.60 N/cm2, rearfoot right 9.51 N/cm2/forefoot left 8.23 N/cm2, forefoot right 8.59 N/cm2). With increasing age, the load in the left foot shifted from the rearfoot to the forefoot as well as the maximum pressure (p ≤ 0.02 and 0.03; poor effect size). With increasing BMI, the body weight shifted to the left and right rearfoot (p ≤ 0.001, poor effect size). As BMI increased, so did the maximum pressure in all areas (p ≤ 0.001 and 0.03, weak to moderate effect size). There were significant differences in weight and maximum pressure distribution in the forefoot and rearfoot in the different age groups, especially between younger (18–40 years) and older (41–65 years) subjects. Discussion Healthy individuals aged from 18 to 65 years were found to have a balanced weight distribution in an aspect ratio, with a 20% greater load of the rearfoot. Age and BMI were found to be influencing factors of the weight and maximum pressure distribution, especially between younger and elder subjects. The collected standard reference values allow comparisons with other studies and can serve as a guideline in clinical practice and scientific studies.


2018 ◽  
Vol 11 (1) ◽  
Author(s):  
Hamad S. Al Amer ◽  
Mohamed A. Sabbahi ◽  
Hesham N. Alrowayeh ◽  
William J. Bryan ◽  
Sharon L. Olson

2013 ◽  
Vol 21 ◽  
pp. S95 ◽  
Author(s):  
I.A. Baert ◽  
A. Mahmoudian ◽  
I. Jonkers ◽  
F. Staes ◽  
F.P. Luyten ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Juniper A. Lake ◽  
Erin M. Brannick ◽  
Michael B. Papah ◽  
Cory Lousenberg ◽  
Sandra G. Velleman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document